Clinical approach to fertility making-decisions in breast cancer patients by Vicenta Almonacid, Ana Lluch, Begoña Bermejo

Get full text

Cáncer y fertilidad by Begoña Bermejo, Blanca Navarro, Ana Lluch

Get full text

A study about the referral oncological patients to the unit of psycho-oncology according medical criteria by Pilar Moreno, Vicenta Almonacid, Ana Lluch

Get full text

Análisis del proceso de enfermedad: variables médicas y psicológicas by Pilar Moreno, Vicenta Almonacid, Silvia Queipo, Ana Lluch

Get full text

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma by Birlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, Eduardo Tormo, Eduardo Tormo, Begoña Pineda, Begoña Pineda, Begoña Pineda, Paula Cabello, Elisa Alonso, Elisa Alonso, Begoña Bermejo, Begoña Bermejo, Begoña Bermejo, Cristina Hernando, Cristina Hernando, María Teresa Martínez, María Teresa Martínez, Ana Rovira, Ana Rovira, Joan Albanell, Joan Albanell, Joan Albanell, Federico Rojo, Federico Rojo, Octavio Burgués, Octavio Burgués, Juan Miguel Cejalvo, Juan Miguel Cejalvo, Ana Lluch, Ana Lluch, Ana Lluch, Ana Lluch, Pilar Eroles, Pilar Eroles, Pilar Eroles

Get full text

Immunological Landscape of HER-2 Positive Breast Cancer by Santiago Moragon, Cristina Hernando, Maria Teresa Martinez-Martinez, Marta Tapia, Belen Ortega-Morillo, Ana Lluch, Begoña Bermejo, Juan Miguel Cejalvo

Get full text

Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator by María Teresa Martínez, Sara S Oltra, María Peña-Chilet, Elisa Alonso, Cristina Hernando, Octavio Burgues, Isabel Chirivella, Begoña Bermejo, Ana Lluch, Gloria Ribas

Get full text

rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility. by Maria Peña-Chilet, Maider Ibarrola-Villava, Manuel Martin-González, Marta Feito, Cristina Gomez-Fernandez, Dolores Planelles, Gregorio Carretero, Ana Lluch, Eduardo Nagore, Gloria Ribas

Get full text

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients by Begoña Pineda, Angel Diaz-Lagares, José Alejandro Pérez-Fidalgo, Octavio Burgués, Inés González-Barrallo, Ana B. Crujeiras, Juan Sandoval, Manel Esteller, Ana Lluch, Pilar Eroles

Get full text

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective by Cristina Hernando, Belén Ortega-Morillo, Marta Tapia, Santiago Moragón, María Teresa Martínez, Pilar Eroles, Iris Garrido-Cano, Anna Adam-Artigues, Ana Lluch, Begoña Bermejo, Juan Miguel Cejalvo

Get full text

Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies by Marta Tapia, Cristina Hernando, María Teresa Martínez, Octavio Burgués, Cristina Tebar-Sánchez, Ana Lameirinhas, Anna Ágreda-Roca, Sandra Torres-Ruiz, Iris Garrido-Cano, Ana Lluch, Begoña Bermejo, Pilar Eroles

Get full text

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer by Sandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano, Ana Lameirinhas, Federico Rojo, Juan Madoz-Gúrpide, Octavio Burgués, Cristina Hernando, Begoña Bermejo, María Teresa Martínez, Ana Lluch, Juan Miguel Cejalvo, Pilar Eroles

Get full text

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer by Iris Garrido-Cano, Vera Constâncio, Anna Adam-Artigues, Ana Lameirinhas, Soraya Simón, Belen Ortega, María Teresa Martínez, Cristina Hernando, Begoña Bermejo, Ana Lluch, Paula Lopes, Rui Henrique, Carmen Jerónimo, Juan Miguel Cejalvo, Pilar Eroles

Get full text

HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women by Sara S. Oltra, Juan Miguel Cejalvo, Eduardo Tormo, Marta Albanell, Ana Ferrer, Marta Nacher, Begoña Bermejo, Cristina Hernando, Isabel Chirivella, Elisa Alonso, Octavio Burgués, Maria Peña-Chilet, Pilar Eroles, Ana Lluch, Gloria Ribas, María Teresa Martinez

Get full text

miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies by Iris Garrido‐Cano, Anna Adam‐Artigues, Ana Lameirinhas, Juan F. Blandez, Vicente Candela‐Noguera, Federico Rojo, Sandra Zazo, Juan Madoz‐Gúrpide, Ana Lluch, Begoña Bermejo, Felix Sancenón, Juan Miguel Cejalvo, Ramón Martínez‐Máñez, Pilar Eroles

Get full text

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth by Felipe Slebe, Federico Rojo, Maria Vinaixa, Mar García-Rocha, Giorgia Testoni, Marc Guiu, Evarist Planet, Sara Samino, Enrique J. Arenas, Antoni Beltran, Ana Rovira, Ana Lluch, Xavier Salvatella, Oscar Yanes, Joan Albanell, Joan J. Guinovart, Roger R. Gomis

Get full text

miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer by Paula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues, Jaume Forés-Martos, María Teresa Martínez, Cristina Hernando, Sandra Zazo, Juan Madoz-Gúrpide, Ana Rovira, Octavio Burgués, Federico Rojo, Joan Albanell, Ana Lluch, Begoña Bermejo, Juan Miguel Cejalvo, Pilar Eroles

Get full text

Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer by Anna Adam-Artigues, Iris Garrido-Cano, Juan Antonio Carbonell-Asins, Ana Lameirinhas, Soraya Simón, Belén Ortega-Morillo, María Teresa Martínez, Cristina Hernando, Vera Constâncio, Octavio Burgues, Begoña Bermejo, Rui Henrique, Ana Lluch, Carmen Jerónimo, Pilar Eroles, Juan Miguel Cejalvo

Get full text

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies. by Rocio Vicario, Vicente Peg, Beatriz Morancho, Mariano Zacarias-Fluck, Junjie Zhang, Águeda Martínez-Barriocanal, Alexandra Navarro Jiménez, Claudia Aura, Octavio Burgues, Ana Lluch, Javier Cortés, Paolo Nuciforo, Isabel T Rubio, Elisabetta Marangoni, James Deeds, Markus Boehm, Robert Schlegel, Josep Tabernero, Rebecca Mosher, Joaquín Arribas

Get full text

Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors by Jesús Fuentes-Antrás, Ana Martínez-Rodríguez, Kissy Guevara-Hoyer, Igor López-Cade, Víctor Lorca, Alejandro Pascual, Alicia de Luna, Carmen Ramírez-Ruda, Jennifer Swindell, Paloma Flores, Ana Lluch, David W. Cescon, Pedro Pérez-Segura, Alberto Ocaña, Frederick Jones, Fernando Moreno, Vanesa García-Barberán, José Ángel García-Sáenz

Get full text